Presented by: Simon Filmar Dr. med.
Asklepios Klinik Barmbek

Introduction

Laser enucleation of the prostate with the thulium laser (ThuLEP) is a procedure for the surgical treatment of benign prostate hyperplasia (BPH). 

Materials

A collective of 503 patients who received ThuLEP in the period from August 1st, 2021 to July 31st, 2022 in the urological department of the Asklepios Klinik Barmbek for BPH were examined retrospectively. Preoperative and intraoperative parameters were defined and their influence on the occurrence of postoperative bleeding requiring intervention and the need for intraoperative electrocoagulation was evaluated.

Results

,

In 41.2% (n=207) of all cases, intraoperative electrocoagulation was necessary for ThuLEP. Independent risk factors for intraoperative electrocoagulation in ThuLEP were the occurrence of an intraoperative capsular perforation (p=0.005) and a higher resection weight (p=0.002). In 4.2% (n=21) of the cases, secondary bleeding requiring intervention was observed. There was statistically significant secondary bleeding requiring intervention with a higher preoperative prostate volume (p=0.004), a higher resection weight (p=0.004) and intraoperative electrocoagulation in ThuLEP (p=0.048).

Conclusion

The need for intraoperative electrocoagulation in ThuLEP was associated with an increased rate of postoperative bleeding requiring intervention. Independent risk factors for the need for electrocoagulation were intraoperative perforation of the prostate capsule and increased resection weight.

Funding

None.

Co-Authors

Andreas Gross, Prof. Dr.
Asklepios Klinik Barmbek

Clemens Rosenbaum, PD Dr.
Asklepios Klinik Barmbek

Benedikt Becker, Dr. med.
Asklepios Klinik Barmbek

Christopher Netsch, Dr. Dr. habil.
Asklepios Klinik Barmbek